Pharmaceutical Research and Manufacturers of America CEO Stephen Ubl met with Senate Finance Committee ranking Democrat Ron Wyden Tuesday (July 9) as the committee negotiates key components of drug-pricing legislation. Wyden is pushing a Part D provision that would force drug makers to pay back Medicare when prices rise faster than inflation. “I’m in the process of regulating pharmaceutical industry to reduce prescription drug prices. People come in and want to be heard,” Wyden told Inside Drug Pricing . PhRMA...